期刊文献+

MMPs及TIMPs在滋养细胞疾病中表达的分析 被引量:6

The Expression of MMPs and their inhibitors-TIMPs in Gestational Trophoblastic Disease
下载PDF
导出
摘要 目的 :分析基质金属蛋白酶 (MMPs)及其组织抑制物 (TIMPs)在滋养细胞疾病中表达水平与预后的关系。方法 :采用免疫组化S P法检测 17例正常绒毛、39例葡萄胎 (HM)、4 2例侵蚀性葡萄胎 (IM)和 2 0例绒毛膜癌 (CC)组织中MMP 2、MMP 9及其TIMP 1、TIMP 2的表达情况。结果 :葡萄胎恶变组MMP 2、MMP 9表达较正常绒毛和葡萄胎未恶变组高 (P =0 .0 0 0 ,0 .0 0 0 ;P =0 .0 4 0 ,0 .0 11)。未化疗滋养细胞肿瘤 (包括IM和CC)MMP 2表达强于早孕绒毛和葡萄胎组 (P均 =0 .0 0 0 ) ,而≥ 3疗程化疗后MMP 2、9表达明显低于未化疗和≤ 2疗程化疗组 (P =0 .0 0 0 ,0 .0 35 ;P =0 .0 10 ,0 .0 18) ,TIMP 1在未化疗滋养细胞肿瘤组表达低于早孕绒毛和葡萄胎组 (P =0 .0 0 5 ,P =0 .0 0 0 )。MMP 2在Ⅱ、Ⅲ期的表达明显强于Ⅰ期 (P均 =0 .0 0 0 ) ,WHO预后评分中、高危者明显强于低危者 (P =0 .0 0 2 ,P =0 .0 0 5 )。结论 :MMPs及TIMPs表达水平高低与滋养细胞疾病预后有关 ,深入了解两者在滋养细胞疾病中的生物作用 。 Objective: To investigate the expression of MMPs and their inhibitors-TIMPs in gestational trophoblastic disease and to assess the relationship between the expression of MMPs and some prognostic factors. Methods: The expression of MMPs and TIMPs was detected by immunohistochemistry in 17 cases of normal villi and 101 cases of trophoblastic disease [39 hydatidiform mole (HM), 42 invasive hydatidiform mole (IM), and 20 choroicarcinomas (CC)]. Results: The expression of MMP-2?MMP-9 was higher in malignant transformed mole than that in normal villi and non-malignant transformed mole (P=0.000, 0.000; P=0.040, 0.011, respectively). MMP-2 expression in trophoblastic tumor (IM+CC) groupswithout chemotherapy was significantly higher than that in the groups of normal villi and hydatidiform mole (P=0.000), while it declined after more than 3 chemotherapeutic regimens and was lower than that in no chemotherapy and less than 2 chemotherapeutic regimens (P=0.000, P=0.035), similar of MMP-9. There was significant difference about TIMP-1 expression between trophoblastic tumor groups without chemotherapy and normal villi?hydatidiform mole (P=0.005, P=0.000). Compared with that of stageⅠ(WHO) , expression of MMP-2 in the stage Ⅱand Ⅲ was significantly increased(P= 0.000,P=0.000). The value of MMP-2 in the cases with middle or high risk in WHO prognostic scoring system was higher than in the cases with low risk (P=0.002, P=0.005). Conclusion: The expression of MMPs and their inhibitors TIMPs has the close relationship with the prognostic factors in gestational trophoblastic disease. To study the biologic function of MMPs and their inhibitors in GTD can help us to find a new method to deal with the drug resistance.
出处 《实用妇产科杂志》 CAS CSCD 北大核心 2004年第4期231-233,i009,共4页 Journal of Practical Obstetrics and Gynecology
关键词 基质金属蛋白酶 基质金属蛋白酶抑制物 妊娠滋养细胞疾病 Matrix metalloproteinase Tissue inhibitors of matrix metalloproteinase Gestational trophoblastic disease
  • 相关文献

参考文献8

  • 1Goldstein DP.Gestational triphoblastic disease.In:Brerk JS,Adash EY,Hillard PA,eds.Novak's gynecology.12thed.Canada:Williams&Wilkins,1996,1261. 被引量:2
  • 2Poulaki V,Mitsiades CS,Mitsiades N.The role of Fas and Fasl as mediators of anticancer Chemotherapy.Drug Resist Updat,2001,4(4):233. 被引量:1
  • 3Rong Niu,Tomomitsu Okamoto,Katsutoshi Iwase,et al.Quantitative analysis of matrix metalloproteinase-2 and -9,and their tissue inhibitor-1 and -2 in human placenta throughoout gestation.Life Science,2000,66(12):1127. 被引量:1
  • 4Vegh GL,Selcuk-Tuncer Z,Fulop V,et al.Matrix metalloproteinases and their inhibitors in gestational trophoblastic diseases and normal placental.Gynecol Oncol,1999,75(2):248. 被引量:1
  • 5Cai W,Song JD.Expression of matrix metalloproteinase and tissue inhibitors in ovariantumors.Ai Zheng,2002,21(1):91. 被引量:1
  • 6马正中等主编..诊断细胞病理学[M].郑州:河南科学技术出版社,2000:897.
  • 7庄黎译.Bayer公司及Agiuron公司在MMP抑制剂领域的竞争.国医药工业信息,1995,(5):6-6. 被引量:2
  • 8李志英,向阳,戴理,程国钧,张德永,杨秀玉,宋鸿钊.基质金属蛋白酶及其组织抑制物预测葡萄胎恶变的研究[J].中华妇产科杂志,2000,35(9):547-550. 被引量:24

二级参考文献2

共引文献25

同被引文献72

引证文献6

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部